Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
Crossref DOI link: https://doi.org/10.1186/s13075-016-1144-5
Published Online: 2016-10-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keil, Andreas
Hall, Sean R.
Körner, Meike
Herrmann, Martin
Schmid, Ralph A.
Frese, Steffen
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (#310030_140964)
LUNIRI non-profit organization (n/a)